ESTRO: HPV Status, Smoking Affect Outcomes in Oropharyngeal Cancer
Patients with oropharyngeal cancer who are infected with human papilloma virus (HPV) respond better to radiotherapy, without addition of chemotherapy.
Diagnosis & Disease Information
Tobacco Exposure Increases Risk of Oropharyngeal Cancer Progression, Death
Patients have a risk of progression and risk of death from oropharyngeal cancer that increases directly as a function of tobacco exposure at diagnosis and during therapy.
Oral Cancers Confirmed as Most Expensive to Treat
Head and neck cancers are associated with significant morbidity, including payments to health care providers, health care services, and health insurance; furthermore, approximately half of H&N cancer survivors return to work.
Electrochemotherapy Controls Growth of Head and Neck Tumors
Electrochemotherapy controls local tumors in head and neck cancers, according to an announcement from OncoSec Medical, Inc.
Exercises Can Improve Short-Term Swallowing Function in Head and Neck Cancer
Patients who perform prophylactic swallowing exercises after undergoing chemoradiation therapy (CRT) for head and neck cancer had improved swallowing function at 3 and 6 months but not immediately after treatment or at 9 or 12 months.
New Treatment Offers Benefit for Hypoxic Laryngeal Tumors
Accelerated radiotherapy plus carbogen and nicotinamide improves regional, not local, control.
H&N Cancers Respond to Reovirus, Platin, Taxane Combo
A reovirus-based vaccine that sensitizes tumor cells to treatment with carboplatin and paclitaxel chemotherapy shrinks head and neck tumors, according to a recent study published in the April 1 issue of Clinical Cancer Research.
Head and Neck Cancer Trial Completes Enrollment
The trial will compare intravenous administration of REOLYSIN with the chemotherapy combination of paclitaxel and carboplatin versus the chemotherapy alone.
CDC Ad Campaign, ‘Tips from Former Smokers,’ Illustrates Harsh Realities
“Tips from Former Smokers,” a hard-hitting national ad campaign launched by the Centers for Disease Control and Prevention (CDC) that depicts the healths risks of smoking and exposure to secondhand smoke, begins Monday, March 19, and will run for at least 12 weeks on television, radio, and billboards, online, and in theaters, magazines, and newspapers nationwide.
Study Indicates Dissection of Level IIb in LSCC Generally Unnecessary
A team of researchers in Turkey have found that dissection of the level IIb area in patients with laryngeal squamous cell carcinoma (LSCC) may not always be necessary.
- Loading...
Loading...
Loading... 
Loading...